Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
967.8 INR | +0.82% | -0.80% | +27.44% |
09/05 | Transcript : Alembic Pharmaceuticals Limited, Q4 2024 Earnings Call, May 09, 2024 | |
09/05 | Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q4 | MT |
Sales 2024 | 6.23TCr 75Cr | Sales 2025 * | 6.99TCr 84Cr | Capitalization | 19TCr 228.55Cr |
---|---|---|---|---|---|
Net income 2024 | 615.8Cr 7.4Cr | Net income 2025 * | 697.8Cr 8.38Cr | EV / Sales 2024 | 3.11 x |
Net Debt 2024 * | 261.68Cr 3.14Cr | Net cash position 2025 * | 84Cr 1Cr | EV / Sales 2025 * | 2.71 x |
P/E ratio 2024 |
31.4
x | P/E ratio 2025 * |
27.2
x | Employees | 14,593 |
Yield 2024 * |
0.92% | Yield 2025 * |
0.9% | Free-Float | 29.28% |
Latest transcript on Alembic Pharmaceuticals Limited
1 day | +0.82% | ||
1 week | -0.80% | ||
Current month | -3.19% | ||
1 month | +3.13% | ||
3 months | -3.63% | ||
6 months | +31.26% | ||
Current year | +27.44% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 01/83/01 | |
Director of Finance/CFO | 64 | 18/03/18 | |
Manisha Saraf
CMP | Compliance Officer | - | 01/23/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 01/83/01 | |
Director of Finance/CFO | 64 | 18/03/18 | |
Director/Board Member | 56 | 04/15/04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +5.41% | - | |
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
18/24/18 | 967.8 | +0.82% | 4,260 |
17/24/17 | 959.9 | -1.04% | 43,212 |
16/24/16 | 970 | +0.19% | 63,359 |
15/24/15 | 968.2 | +0.31% | 82,621 |
14/24/14 | 965.2 | +1.25% | 86,264 |
Delayed Quote NSE India S.E., May 18, 2024 at 12:32 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.44% | 228.36Cr | |
+32.09% | 69TCr | |
+29.39% | 58TCr | |
-1.34% | 37TCr | |
+20.34% | 33TCr | |
+7.39% | 29TCr | |
+13.75% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+8.49% | 17TCr |
- Stock Market
- Equities
- APLLTD Stock